Patient Guide: Coformulation of Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab (MK-3475) Monotherapy for Programmed Cell Death 1 Ligand 1 (PD-L1) Positive Metastatic Non-Small Cell Lung Cancer (MK-7684A-003, KEYVIBE-003)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 188 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04738487
Status: ACTIVE_NOT_RECRUITING
Condition: Lung Neoplasms, Non-Small-Cell Lung Carcinoma
Phase: PHASE3

Find a Study Location Near You

This study is available at 188 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Boca Raton, Florida
  • Peoria, Illinois
  • Springfield, Missouri
  • • And 185 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily